Longitudinal analysis will be necessary to determine whether clonal expansion promoted by the acquisition of somatic EIF6 mutations delays or abrogates the emergence of hematological complications such as aplastic anemia, myelodysplastic syndrome (MDS), or acute myeloid leukemia (AML). This evidence concerns the gene EIF6 and myelodysplastic syndrome.